Literature DB >> 22830401

The multifaceted actions of PTHrP in skeletal metastasis.

Fabiana N Soki1, Serk In Park, Laurie K McCauley.   

Abstract

PTHrP, identified during the elucidation of mediators of malignancy-induced hypercalcemia, plays numerous roles in normal physiology as well as pathological conditions. Recent data support direct functions of PTHrP in metastasis, particularly from tumors with strong bone tropism. Bone provides a unique metastatic environment because of mineralization and the diverse cell populations in the bone marrow. PTHrP is a key regulator of tumor-bone interactions and regulates cells in the bone microenvironment through proliferative and prosurvival activities that prime the 'seed' and the 'soil' of the metastatic lesion. This review highlights recent findings regarding the role of PTHrP in skeletal metastasis, including direct actions in tumor cells, as well as alterations in the bone microenvironment and future perspectives involving the potential roles of PTHrP in the premetastatic niche, and tumor dormancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22830401      PMCID: PMC3566558          DOI: 10.2217/fon.12.76

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  99 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.

Authors:  Serk In Park; Laurie K McCauley
Journal:  Endocr Relat Cancer       Date:  2012-05-03       Impact factor: 5.678

3.  Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.

Authors:  H L Uy; G R Mundy; B F Boyce; B M Story; C R Dunstan; J J Yin; G D Roodman; T A Guise
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

Review 4.  Targeting anoikis resistance in prostate cancer metastasis.

Authors:  Shinichi Sakamoto; Natasha Kyprianou
Journal:  Mol Aspects Med       Date:  2010-02-11

5.  Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia.

Authors:  F Asadi; M Farraj; R Sharifi; S Malakouti; S Antar; S Kukreja
Journal:  Hum Pathol       Date:  1996-12       Impact factor: 3.466

Review 6.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

7.  Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer.

Authors:  M Iwamura; P A di Sant'Agnese; G Wu; C M Benning; A T Cockett; L J Deftos; P A Abrahamsson
Journal:  Cancer Res       Date:  1993-04-15       Impact factor: 12.701

Review 8.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

9.  Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; W J Burtis; T Wu; D Goumas; A E Broadus
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

10.  Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis.

Authors:  Li Yang; Claire M Edwards; Gregory R Mundy
Journal:  J Bone Miner Res       Date:  2010-08       Impact factor: 6.741

View more
  38 in total

Review 1.  Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.

Authors:  Ami Patel; Harika Sabbineni; Andrea Clarke; Payaningal R Somanath
Journal:  Life Sci       Date:  2016-05-28       Impact factor: 5.037

Review 2.  Multiple Myeloma and Bone: The Fatal Interaction.

Authors:  Silvia Marino; G David Roodman
Journal:  Cold Spring Harb Perspect Med       Date:  2018-08-01       Impact factor: 6.915

3.  Prevention of breast cancer skeletal metastases with parathyroid hormone.

Authors:  Srilatha Swami; Joshua Johnson; Lance A Bettinson; Takaharu Kimura; Hui Zhu; Megan A Albertelli; Rachelle W Johnson; Joy Y Wu
Journal:  JCI Insight       Date:  2017-09-07

4.  Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.

Authors:  Nicole A Kohart; Said M Elshafae; Aylin A Demirer; Wessel P Dirksen; Justin T Breitbach; Sherry T Shu; Jingyu Xiang; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2019-10-08

Review 5.  Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.

Authors:  Sneha Soni; Meaghan Torvund; Chandi C Mandal
Journal:  Clin Exp Metastasis       Date:  2021-02-16       Impact factor: 5.150

Review 6.  MicroRNAs in the control of metastatic bone disease.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Trends Endocrinol Metab       Date:  2014-05-05       Impact factor: 12.015

7.  Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.

Authors:  Ah Young Jun; Hyun-Jeong Kim; Kwang-Kyun Park; Kun Ho Son; Dong Hwa Lee; Mi-Hee Woo; Won-Yoon Chung
Journal:  Invest New Drugs       Date:  2013-05-15       Impact factor: 3.850

Review 8.  The gut microbiota can be a potential regulator and treatment target of bone metastasis.

Authors:  Kelly F Contino; Hariom Yadav; Yusuke Shiozawa
Journal:  Biochem Pharmacol       Date:  2022-01-15       Impact factor: 5.858

Review 9.  Role of myokines and osteokines in cancer cachexia.

Authors:  Fabrizio Pin; Lynda F Bonewald; Andrea Bonetto
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

10.  PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability.

Authors:  Jason R Pitarresi; Robert J Norgard; Anna M Chiarella; Kensuke Suzuki; Basil Bakir; Varun Sahu; Jinyang Li; Jun Zhao; Benoît Marchand; Maximilian D Wengyn; Antony Hsieh; Il-Kyu Kim; Amy Zhang; Karine Sellin; Vivian Lee; Shigetsugu Takano; Yoji Miyahara; Masayuki Ohtsuka; Anirban Maitra; Faiyaz Notta; Richard Kremer; Ben Z Stanger; Anil K Rustgi
Journal:  Cancer Discov       Date:  2021-02-15       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.